• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy.

作者信息

Morales E, Andrés A, González E, Herrero J C, Muñoz M A, Ortiz M, Espejo B, Lumbreras C, Morales J M, Aguado J M

机构信息

Nephrology Department and Infectious Diseases Unit, Hospital 12 de Octubre, Madrid, Spain.

出版信息

Transplant Proc. 2002 Feb;34(1):73-4. doi: 10.1016/s0041-1345(01)02671-9.

DOI:10.1016/s0041-1345(01)02671-9
PMID:11959191
Abstract
摘要

相似文献

1
Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy.在接受抗淋巴细胞抗体作为诱导治疗的肾移植受者中，使用更昔洛韦或抗巨细胞病毒免疫球蛋白预防巨细胞病毒疾病。
Transplant Proc. 2002 Feb;34(1):73-4. doi: 10.1016/s0041-1345(01)02671-9.
2
Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.接受诱导性抗淋巴细胞抗体治疗的肾移植受者使用更昔洛韦进行巨细胞病毒预防。
Transplant Proc. 2004 Jul-Aug;36(6):1847-9. doi: 10.1016/j.transproceed.2004.07.021.
3
Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.在接受抗淋巴细胞抗体治疗的巨细胞病毒血清学阳性肾移植和肝移植受者中，先进行静脉注射更昔洛韦抢先治疗后，口服阿昔洛韦或更昔洛韦预防巨细胞病毒疾病的疗效。
Transplantation. 1998 Dec 27;66(12):1780-6. doi: 10.1097/00007890-199812270-00036.
4
[Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].更昔洛韦抢先治疗对肾移植受者发生巨细胞病毒病高风险（R-/D+）的有效性
Rev Invest Clin. 2002 May-Jun;54(3):198-203.
5
Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial.更昔洛韦抢先治疗预防巨细胞病毒抗体阳性肾移植受者的巨细胞病毒疾病。一项随机对照试验。
Ann Intern Med. 1995 Jul 1;123(1):18-26. doi: 10.7326/0003-4819-123-1-199507010-00002.
6
Cytomegalovirus prophylaxis in pediatric renal transplant recipients.小儿肾移植受者的巨细胞病毒预防
Transplant Proc. 1993 Feb;25(1 Pt 2):1414-5.
7
Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients.巨细胞病毒高效价免疫球蛋白联合更昔洛韦与单用巨细胞病毒高效价免疫球蛋白对高危心脏移植受者进行预防的比较
Transplantation. 2004 Mar 27;77(6):890-7. doi: 10.1097/01.tp.0000119722.37337.dc.
8
Eradication of cytomegalovirus reactivation disease using high-dose acyclovir and targeted intravenous ganciclovir in kidney and kidney/pancreas transplantation.在肾移植和肾/胰腺移植中使用大剂量阿昔洛韦和靶向静脉注射更昔洛韦根除巨细胞病毒再激活疾病
Transplantation. 1997 Sep 27;64(6):931-3. doi: 10.1097/00007890-199709270-00026.
9
Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease.对巨细胞病毒疾病发生风险高的患者进行缬更昔洛韦预防治疗。
Transpl Infect Dis. 2004 Sep;6(3):101-9. doi: 10.1111/j.1399-3062.2004.00066.x.
10
Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.早期更昔洛韦治疗可有效控制病毒血症，并避免对患有巨细胞病毒血症的肾移植患者进行巨细胞病毒（CMV）预防。
Clin Transplant. 1996 Dec;10(6 Pt 1):550-5.

引用本文的文献

1
Gastrointestinal Infections Caused by Cytomegalovirus.巨细胞病毒引起的胃肠道感染
Curr Infect Dis Rep. 2003 Apr;5(2):101-107. doi: 10.1007/s11908-003-0044-4.